Active Psoriatic Arthritis Clinical Trials

24 clinical trials for Active Psoriatic Arthritis across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Korean Post-marketing Surveillance for Xeljanz XR — RECRUITING
• A PHASE 2 MULTICENTER, RANDOMIZED, PLATFORM STUDY OF TARGETED THERAPIES FOR THE TREATMENT OF ADULT SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS — RECRUITING · PHASE2
• A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, AND PLACEBO-CONTROLLED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ZASOCITINIB (TAK-279) IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS STRATIFIED BY PRIOR BIOLOGIC USE (LATITUDE-PSA- 3002) — RECRUITING · PHASE3
• A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF JNJ-77242113 FOR THE TREATMENT OF BIOLOGIC-EXPERIENCED AND BIOLOGIC-NAÏVE PARTICIPANTS WITH ACTIVE PSORIATIC ARTHRITIS — RECRUITING · PHASE3
• A PHASE 3, PARALLEL-GROUP, RANDOMIZED, DOUBLE-BLIND, 3-ARM, PLACEBOCONTROLLED, MULTICENTER STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS SONELOKIMAB IN MALE AND FEMALE PARTICIPANTS AGED 18 YEARS AND OVER WITH ACTIVE PSORIATIC ARTHRITIS WHO ARE NAIVE TO BIOLOGIC DMARDS — RECRUITING · PHASE3
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 2B/3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF IZOKIBEP IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS — RECRUITING · PHASE2
• A PHASE 3B, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF SUBCUTANEOUSLY ADMINISTERED GUSELKUMAB IN IMPROVING THE SIGNS AND SYMPTOMS AND INHIBITING RADIOGRAPHIC PROGRESSION IN PARTICIPANTS WITH ACTIVE PSORIATIC ARTHRITIS (APEX) — RECRUITING · PHASE3
• A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF 2 DOSES OF TOFACITINIB (CP 690,550) OR ADALIMUMAB IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS — RECRUITING · PHASE3
• A randomized, double-blind, placebo-controlled trial of golimumab+methotrexate versus methotrexate alone in methotrexate-naïve patients with psoriatic arthritis — COMPLETED · PHASE3
• A Phase 3 Study of Guselkumab in Subjects with Active Psoriatic Arthritis — COMPLETED · PHASE3
• BI 655066 / ABBV-066 / risankizumab compared to placebo in patients with active psoriatic arthritis — COMPLETED · PHASE2
• ​​A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of JNJ-77242113 for the Treatment of Biologic-naïve Participants with Active Psoriatic Arthritis​ — TERMINATED · PHASE3
• A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety ofJNJ-77242113 for the Treatment of Biologic-experienced and Biologic-naïve Participants with Active Psoriatic Arthritis — TERMINATED · PHASE3
• A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants with Active Psoriatic Arthritis who are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs — TERMINATED · PHASE3
• A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants with Active Psoriatic Arthritis — TERMINATED · PHASE2
• A Multi-center, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants with Active Psoriatic Arthritis (PsA) who are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or had Previously Received TNFα Inhibitor Treatment — TERMINATED · PHASE3
• Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2) — ACTIVE_NOT_RECRUITING · PHASE3
• Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) — COMPLETED · PHASE3
• Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis — WITHDRAWN · PHASE4
• Efficacy and Safety Study of SUNPG1623 — COMPLETED · PHASE2
• Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) — COMPLETED · PHASE2
• A PHASE 4, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF GUSELKUMAB ADMINISTERED SUBCUTANEOUSLY IN BIO-NAIVE PARTICIPANTS WITH ACTIVE PSORIATIC ARTHRITIS AXIAL DISEASE — COMPLETED · PHASE4
• Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease — COMPLETED · PHASE3
• A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, ACTIVE REFERENCE (ADALIMUMAB) STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS — COMPLETED · PHASE3

Refine this search